Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Honeywell Aerospace Inc.HONA · Entity 1656 | Director | August 03, 2026 | August 05, 2026 |
| LOWES COMPANIES INCLOW · Entity 2896 | EVP, Chief Financial Officer | April 01, 2022 | April 05, 2022 |
| NIKE, Inc.NKE · Entity 2537 | EVP: CFO | September 01, 2026 | September 03, 2026 |
| PFIZER INCPFE · Entity 2863 | Chief Financial Officer & EVP | March 03, 2026 | March 05, 2026 |
| TAPESTRY, INC.TPR · Entity 2309 | Director | November 15, 2022 | November 16, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Honeywell Aerospace Inc.
Report date August 03, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 572 |
Reported balance
After 2026-08-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-03 · Grant · Acquired 572 · Balance 572 F1: Instrument converts to Issuer's Common Stock on a one-for-one basis. F2: The Restricted Stock Units shall vest on April 15, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Instrument converts to Issuer's Common Stock on a one-for-one basis.
F2: The Restricted Stock Units shall vest on April 15, 2027.
LOWES COMPANIES INC
Report date April 01, 2022 · Filed April 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 56,663 |
Ending reported balance
After 2022-04-01 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-04-01 · Exercise / conversion · Acquired 38,220 · Balance 72,543 F1: Each performance share unit represented a contingent right to receive one share of the Issuer's common stock upon the achievement of certain pre-established metrics over the three-year performance period ending at the end of fiscal 2021. Row 2 · 2022-04-01 · Tax withholding · Disposed 21,230 · Balance 51,313 F2: Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units and restricted shares granted on April 1, 2019. Row 3 · 2022-04-01 · Grant · Acquired 5,350 · Balance 56,663 F3: Restricted stock granted pursuant to 2006 Long-Term Incentive Plan. The shares will fully vest on April 1, 2025. |
| Performance Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-04-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-04-01 · Exercise / conversion · Disposed 38,220 · Balance 0 F4: At the vest date, the performance share units earned converted into an equivalent number of shares of the Issuer's common stock. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $202.40 · Expires 2032-04-01 | Direct | 18,265 |
Reported balance
After 2022-04-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-04-01 · Grant · Acquired 18,265 · Balance 18,265 F5: The option vests in three annual installments beginning on April 1, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Each performance share unit represented a contingent right to receive one share of the Issuer's common stock upon the achievement of certain pre-established metrics over the three-year performance period ending at the end of fiscal 2021.
F2: Reflects shares delivered by reporting person to satisfy withholding taxes due upon vesting of performance share units and restricted shares granted on April 1, 2019.
F3: Restricted stock granted pursuant to 2006 Long-Term Incentive Plan. The shares will fully vest on April 1, 2025.
F4: At the vest date, the performance share units earned converted into an equivalent number of shares of the Issuer's common stock.
F5: The option vests in three annual installments beginning on April 1, 2023.
NIKE, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table I · non-derivative | Direct | 71,234 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Grant · Acquired 71,234 · Balance 71,234 F1: Restricted Stock Units ("RSUs") granted under the NIKE, Inc. Stock Incentive Plan; 25% of the total number of RSUs granted vest on each of the first four anniversaries of the date of the grant. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.12 · Expires 2036-09-01 | Direct | 259,946 |
Reported balance
After 2026-09-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-01 · Grant · Acquired 259,946 · Balance 259,946 F2: Stock Option granted under the NIKE, Inc. Stock Incentive Plan; it becomes exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units ("RSUs") granted under the NIKE, Inc. Stock Incentive Plan; 25% of the total number of RSUs granted vest on each of the first four anniversaries of the date of the grant.
F2: Stock Option granted under the NIKE, Inc. Stock Incentive Plan; it becomes exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant.
PFIZER INC
Report date March 03, 2026 · Filed March 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $26.58 · Expires 2031-03-03 | Direct | 216,537 |
Reported balance
After 2026-03-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-03 · Grant · Acquired 216,537 · Balance 216,537 F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
TAPESTRY, INC.
Report date November 15, 2022 · Filed November 16, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,647 |
Reported balance
After 2022-11-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-11-15 · Grant · Acquired 2,430 · Balance 37,647 F1: All of the securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 15, 2023. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $34.98 · Expires 2032-11-15 | Direct | 6,822 |
Reported balance
After 2022-11-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-11-15 · Grant · Acquired 6,822 · Balance 6,822 F2: All of the securities acquired were issued under the Issuer's Stock Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: All of the securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 15, 2023.
F2: All of the securities acquired were issued under the Issuer's Stock Incentive Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CVS HEALTH Corp
Report date November 29, 2018 · Filed November 30, 2018
Section 16 reporting ended · disclosed 2018-11-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 402.9767 |
Reported balance
After 2018-11-29 transaction · row 1
1 source rowRow 1 · 2018-11-29 · Sale · Disposed 25,159 · Balance 402.9767 F1: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.72 and $80.54 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $79.72 and $80.54 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2014 Filed Jan 3, 2014 23:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 14,113 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0001127602-14-001016 · form4.xml · derivative · entry 6 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,113 shares Expires 2014-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/2/2008. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 14,113 | $70.50 | $994,966.50 |
DisclosureSEC source: 0001127602-14-001016 · form4.xml · nonDerivative · entry 3 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,970.0559 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.28 and $70.70 per share. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 14,113 | $34.42 | $485,769.46 |
DisclosureSEC source: 0001127602-14-001016 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,083.0559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2013 Filed Jan 3, 2014 23:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 840 | $59.88 | $50,299.20 |
DisclosureSEC source: 0001127602-14-001016 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,476.0559 Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 108,183 | $54.53 Strike: $54.53 | $5,899,218.99 |
DisclosureSEC source: 0001127602-13-013254 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,183 Underlying: Common Stock · 108,183 shares Expires 2020-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,919 | $54.53 | $104,643.07 |
DisclosureSEC source: 0001127602-13-013254 · form4.xml · nonDerivative · entry 3 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,316.0559 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,067 | $54.53 | $112,713.51 |
DisclosureSEC source: 0001127602-13-013254 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,316.0559 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 25,216 | $54.53 | $1,375,028.48 |
DisclosureSEC source: 0001127602-13-013254 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,869 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/12016 and 50% on 4/1/2018. Read SEC document |
| March 05, 2013 Filed Mar 6, 2013 21:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 632 | $52.30 | $33,053.60 |
DisclosureSEC source: 0001127602-13-009602 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,985.0559 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 21:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 7,947 | $52.66 | $418,489.02 |
DisclosureSEC source: 0001127602-13-007321 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,300 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| February 17, 2013 Filed Feb 19, 2013 21:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 335 | $51.12 | $17,125.20 |
DisclosureSEC source: 0001127602-13-006751 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,353 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| September 13, 2012 Filed Sep 14, 2012 20:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 11,526 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001127602-12-026380 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,052 Underlying: Common Stock · 11,526 shares Expires 2013-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/3/2007. Read SEC document |
| September 13, 2012 Filed Sep 14, 2012 20:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 11,526 | $47.00 | $541,722.00 |
DisclosureSEC source: 0001127602-12-026380 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,520.8264 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| September 13, 2012 Filed Feb 12, 2013 21:30 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 11,526 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001127602-13-005590 · form4a.xml · derivative · entry 2 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,526 shares Expires 2013-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2012 Filed Feb 12, 2013 21:30 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 11,526 | $30.04 | $346,183.41 |
DisclosureSEC source: 0001127602-13-005590 · form4a.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,046.8264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The purpose of this Amended Form 4/A is to correct the common stock ownership balance following the reported stock option transaction. The balance was inadvertently reduced on the original filing due to a computer error. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:06 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 110,912 | $45.07 Strike: $45.07 | $4,998,803.84 |
DisclosureSEC source: 0001127602-12-013295 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,912 Underlying: Common Stock · 110,912 shares Expires 2019-04-02 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:06 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 800 | $45.07 | $36,056.00 |
DisclosureSEC source: 0001127602-12-013295 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,046.8264 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:06 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 27,735 | $45.07 | $1,250,016.45 |
DisclosureSEC source: 0001127602-12-013295 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/2/2015 and 50% on 4/2/2017. Read SEC document |
| February 18, 2012 Filed Feb 21, 2012 21:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 367 | $44.27 | $16,247.09 |
DisclosureSEC source: 0001127602-12-007107 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,963.8264 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 21:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 335 | $44.27 | $14,830.45 |
DisclosureSEC source: 0001127602-12-007107 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,330.8264 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 22:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 7,347 | $43.08 | $316,508.76 |
DisclosureSEC source: 0001127602-12-004956 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,716.8264 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| September 14, 2011 Filed Sep 16, 2011 20:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 5,334 | $0.00 Strike: $22.45 | $0.00 |
DisclosureSEC source: 0001127602-11-025377 · form4.xml · derivative · entry 6 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,334 shares Expires 2012-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2011 Filed Sep 16, 2011 20:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 5,334 | $37.00 | $197,358.00 |
DisclosureSEC source: 0001127602-11-025377 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,635 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 14, 2011 Filed Sep 16, 2011 20:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 5,334 | $22.45 | $119,721.63 |
DisclosureSEC source: 0001127602-11-025377 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2011 Filed Apr 5, 2011 20:18 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 107,178 | $34.98 Strike: $34.96 | $3,749,086.44 |
DisclosureSEC source: 0001127602-11-012396 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,178 Underlying: Common Stock · 107,178 shares Expires 2018-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| April 01, 2011 Filed Apr 5, 2011 20:18 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 28,605 | $34.96 | $1,000,030.80 |
DisclosureSEC source: 0001127602-11-012396 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,097 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse in two equal installments, 50% on 4/1/2014 and 50% on 4/1/2016. Read SEC document |
| March 04, 2011 Filed Mar 8, 2011 21:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 5,000 | $0.00 Strike: $30.26 | $0.00 |
DisclosureSEC source: 0001127602-11-009443 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2011-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 3/7/2003. Read SEC document |
| March 04, 2011 Filed Mar 8, 2011 21:01 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 5,000 | $30.26 | $151,312.50 |
DisclosureSEC source: 0001127602-11-009443 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2011 Filed Feb 16, 2011 21:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 390 | $33.03 | $12,881.70 |
DisclosureSEC source: 0001127602-11-005821 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,551 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 03, 2010 Filed Apr 5, 2010 22:17 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 349 | $36.23 | $12,644.27 |
DisclosureSEC source: 0001127602-10-010571 · form4.xml · nonDerivative · entry 3 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,860.0814 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2010 Filed Apr 5, 2010 22:17 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,916 | $36.23 | $105,646.68 |
DisclosureSEC source: 0001127602-10-010571 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,209.0814 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2010 Filed Apr 5, 2010 22:17 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 95,618 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-10-010571 · form4.xml · derivative · entry 6 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,618 Underlying: Common Stock · 95,618 shares Expires 2017-04-01 F3 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| April 01, 2010 Filed Apr 5, 2010 22:17 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 8,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-010571 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,502.2856 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2013 and 50% on 7/23/2020. Read SEC document |
| February 18, 2010 Filed Feb 19, 2010 20:57 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-005621 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,409.0814 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 17, 2010 Filed Feb 19, 2010 20:57 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 3,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-005621 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,794.2856 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on three equal installments on 2/17/2011, 2/17/2012 and 2/17/2013. Read SEC document |
| February 16, 2010 Filed Feb 17, 2010 21:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-005080 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,118.0814 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| February 12, 2010 Filed Feb 17, 2010 21:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 408 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-005080 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,708.0814 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 20:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 48,178 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-09-008783 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,178 Underlying: Common Stock · 48,178 shares Expires 2016-04-01 F1 · derivative.exercise_date: Option becomes exercisable in three equal installments, commencing 4/1/2010. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 20:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 4,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-008783 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,506 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse 100% on 4/1/2013. Read SEC document |
| February 18, 2009 Filed Feb 20, 2009 21:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 2,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-004382 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,900 F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on three equal installments on 2/18/2010, 2/18/2011 and 2/18/2012. Read SEC document |
| February 13, 2009 Filed Feb 18, 2009 22:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 593 | $27.47 | $16,289.71 |
DisclosureSEC source: 0001127602-09-004130 · form4.xml · nonDerivative · entry 3 Denton David M · CIK 0001428718 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,908.8343 F3 · shares: Surrender of shares in payment of withholding taxes due in connection with a previously reported transaction Read SEC document |
| February 13, 2009 Filed Feb 18, 2009 22:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,100 | $27.47 | $30,217.00 |
DisclosureSEC source: 0001127602-09-004130 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,501.8343 F2 · shares: Surrender of shares in payment of withholding taxes due in connection with a previously reported transaction. Read SEC document |
| February 12, 2009 Filed Feb 18, 2009 22:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 451 | $28.07 | $12,659.57 |
DisclosureSEC source: 0001127602-09-004130 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,601.8343 F1 · shares: Surrender of shares in payment of withholding taxes due in connection with a previously reported transaction. Read SEC document |
| April 01, 2008 Filed Apr 3, 2008 20:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 26,811 | $0.00 Strike: $41.17 | $0.00 |
DisclosureSEC source: 0000064803-08-000041 · doc.xml · derivative · entry 10 Denton David M · CIK 0001428718 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,811 Underlying: Common Stock · 26,811 shares Expires 2015-04-01 F6 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/1/2009. Read SEC document |
| April 01, 2008 Filed Apr 3, 2008 20:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 1,883 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-08-000041 · doc.xml · nonDerivative · entry 3 Denton David M · CIK 0001428718 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,280 F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on 04/01/2013. Read SEC document |
| March 05, 2008 Filed Mar 7, 2008 20:37 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 12,420 | $0.00 Strike: $40.28 | $0.00 |
DisclosureSEC source: 0001428718-08-000002 · doc.xml · derivative · entry 9 Denton David M · CIK 0001428718 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,420 Underlying: Common Stock · 12,420 shares Expires 2018-03-05 F4 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 3/5/2011. Read SEC document |
| March 05, 2008 Filed Mar 7, 2008 20:37 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (PEP) | 1,242 | $0.00 | $0.00 |
DisclosureSEC source: 0001428718-08-000002 · doc.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,242 Read SEC document |
| March 05, 2008 Filed Mar 7, 2008 20:37 UTC | CVS HEALTH Corp CVS · Entity 2884 | PurchaseCommon Stock | 1,242 | $40.23 | $49,965.66 |
DisclosureSEC source: 0001428718-08-000002 · doc.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,368.8343 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.